Amedisys Inc (AMED)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 67,780 127,537 112,037 -539 10,307 2,648 2,330 112,184 118,609 120,939 140,303 190,873 209,072 220,176 247,151 201,676 183,608 166,112 128,263 127,331
Revenue (ttm) US$ in thousands 2,348,324 2,321,060 2,289,626 2,251,407 2,236,382 2,227,658 2,229,409 2,234,331 2,223,199 2,220,452 2,215,949 2,222,225 2,214,112 2,205,500 2,196,085 2,116,978 2,071,519 2,021,492 1,972,053 1,979,978
Net profit margin 2.89% 5.49% 4.89% -0.02% 0.46% 0.12% 0.10% 5.02% 5.34% 5.45% 6.33% 8.59% 9.44% 9.98% 11.25% 9.53% 8.86% 8.22% 6.50% 6.43%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $67,780K ÷ $2,348,324K
= 2.89%

Amedisys Inc's net profit margin has displayed some fluctuations over the analyzed period. The margin started positively at 6.43% in March 2020, showing a slight increase up to 11.25% in June 2021. Thereafter, the margin started to gradually decline, reaching 0.10% in June 2023 but showing a positive uptick at 4.89% in the following quarter. The margin fluctuated between 0.10% and 11.25% during the period under review, with the December 2023 and March 2024 quarters being notably challenging, resulting in negative margins of -0.02% and -0.46% consecutively. However, by December 2024, the net profit margin managed to recover to 2.89%. Overall, the net profit margin of Amedisys Inc has experienced variability, suggesting that the company's profitability performance has seen some ups and downs throughout the given timeframe.


Peer comparison

Dec 31, 2024